- Home
- BLD vs MRNA Comparison
BLD vs MRNA Comparison
Compare BLD & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLD
- MRNA
- Stock Information
- Founded
- BLD 2015
- MRNA 2010
- Country
- BLD United States
- MRNA United States
- Employees
- BLD N/A
- MRNA N/A
- Industry
- BLD Engineering & Construction
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLD Consumer Discretionary
- MRNA Health Care
- Exchange
- BLD Nasdaq
- MRNA Nasdaq
- Market Cap
- BLD 9.3B
- MRNA 11.1B
- IPO Year
- BLD N/A
- MRNA 2018
- Fundamental
- Price
- BLD $380.34
- MRNA $33.30
- Analyst Decision
- BLD Strong Buy
- MRNA Hold
- Analyst Count
- BLD 12
- MRNA 19
- Target Price
- BLD $387.27
- MRNA $48.13
- AVG Volume (30 Days)
- BLD 473.9K
- MRNA 9.9M
- Earning Date
- BLD 08-05-2025
- MRNA 07-31-2025
- Dividend Yield
- BLD N/A
- MRNA N/A
- EPS Growth
- BLD N/A
- MRNA N/A
- EPS
- BLD 19.77
- MRNA N/A
- Revenue
- BLD $5,284,364,000.00
- MRNA $3,177,000,000.00
- Revenue This Year
- BLD N/A
- MRNA N/A
- Revenue Next Year
- BLD $2.90
- MRNA $9.70
- P/E Ratio
- BLD $19.26
- MRNA N/A
- Revenue Growth
- BLD 1.46
- MRNA N/A
- 52 Week Low
- BLD $266.26
- MRNA $23.15
- 52 Week High
- BLD $495.68
- MRNA $129.39
- Technical
- Relative Strength Index (RSI)
- BLD 77.34
- MRNA 70.05
- Support Level
- BLD $339.11
- MRNA $29.72
- Resistance Level
- BLD $390.83
- MRNA $34.39
- Average True Range (ATR)
- BLD 11.54
- MRNA 1.48
- MACD
- BLD 5.73
- MRNA 0.68
- Stochastic Oscillator
- BLD 88.29
- MRNA 88.62
About BLD TopBuild Corp.
TopBuild Corp is an installer and distributor of insulation products. Its operating segments involve the Installation and Specialty Distribution segment. The installation segment provides insulation installation services nationwide through contractor services business. Speciality Distribution segment distributes building and mechanical insulation, insulation accessories and other building product materials for the residential, commercial, and industrial end markets. The majority of revenue is earned from the installation segment. Its main customers are contractors. Other products include gutters, after-paint, garage doors, fireplaces, and fireproofing and stopping. TopBuild operates majorly in the United States.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.